MedTrace Logo

GABA and Beta-cell Regeneration

NCT04375020 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2020-05-07

No results posted yet for this study

Summary

GABA(gamma-Aminobutyric acid) may be used for decreasing anti-gad antibodies and leads beta-cell regeneration.

Conditions

  • Diabetes Mellitus, Type 1

Interventions

DRUG

GABA

GABA nutritional supplement 750mg per day for 6 months

Sponsors & Collaborators

  • Ministry of Health and Population, Egypt

    lead OTHER_GOV

Eligibility

Min Age
18 Years
Max Age
25 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-11-01
Primary Completion
2020-05-01
Completion
2020-05-02

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04375020 on ClinicalTrials.gov